Community Financial Services Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Community Financial Services Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.4K	Buy	+53	New	+$23.5K	﹤0.01%	284

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Community Financial Services Group's VRTX Position: Q2 2026 in Review

Community Financial Services Group opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 53 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #284 among its holdings.

339 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Community Financial Services Group held 53 shares of Vertex Pharmaceuticals worth $26.4K as of Q2 2026.
Vertex Pharmaceuticals was a new Community Financial Services Group position in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Community Financial Services Group's portfolio in Q2 2026, its #284 holding.
339 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Community Financial Services Group's 13F filing for Q2 2026, filed 9 Jul 2026.